Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total neoadjuvant treatment for high-risk locally advanced rectal cancer
ChiCTR-OIN-17012284Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in rectal cancer, sponsored by West China Hospital of Sichuan University. Primary endpoints: Pathologic complete response rate and R0 resection rate. Started Jun 2015; status: recruiting.
02
Drugs
fluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on ChiCTR-OIN-17012284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-17012284.